youtube_live
Q3 2026 earnings • released • EPS beat +2.32% • Revenue miss -0.16%
See resultschevron_right
ALC:NYSE
Alcon AG
US$71.83
arrow_downward
-0.86%(-0.62) 1D
US$71.70
arrow_downward
-0.18% (-0.13)bedtimeAfter hours
Closed: ኖቬም 12, 4:00:04 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
US$73.06
High
US$73.96
Low
US$71.64
Mkt. cap
30.41 ቢ
Avg. vol.
2.08 ሚ
Volume
2.25 ሚ
52-wk high
US$87.64
52-wk low
US$61.84
Beta
0.87
Shares outstanding
483.40 ሚ
No. of employees
25 ሺ
Open
US$73.06
High
US$73.96
Low
US$71.64
Mkt. cap
30.41 ቢ
Avg. vol.
2.08 ሚ
Volume
2.25 ሚ
52-wk high
US$87.64
52-wk low
US$61.84
Beta
0.87
Shares outstanding
483.40 ሚ
No. of employees
25 ሺ
News stories
From web sources and news partners
Yahoo Finance
·
ከ12 ሰዓቶች በፊት
Alcon (SWX:ALC) Stock Could Be 47% Undervalued After Neurotech Acquisition
Investing.com
·
ከ13 ሰዓቶች በፊት
Bernstein cuts Alcon stock price target on Q3 revenue miss
Medtech Insight
·
ከ15 ሰዓቶች በፊት
Alcon Banks On Vivity Pro To Return Implantables To Growth After US Premium IOL Share Loss
Benzinga
·
ከ16 ሰዓቶች በፊት
NVIDIA To $186? Here Are 10 Top Analyst Forecasts For Thursday
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25 ሺ
Founded1945
Headquartersዠኔቭ, Geneva, ስዊዘርላንድ
SectorHealth Care
IndustryMedical device
Websitealcon.com